- Home
- Media centre
- From our CEO
From our CEO
Andrew Witty talks about low cost vaccines on the day of the GAVI pledging conference
Andrew Witty speaks to BBC News about GSK’s recent offer to supply its rotavirus vaccine, Rotarix™, to the GAVI Alliance at a small fraction of developed world prices. Mr Witty also joins the panel of the BBC’s current affairs programme ‘Newsnight’ to discuss the role of philanthropy in the modern world.
The following files require Windows Media Player to view:
BBC News and BBC Radio 4 interviews on low-cost vaccines – June 2011
GSK CEO Andrew Witty tells BBC News and BBC Radio 4 Today programme about GSK’s offer to the GAVI Alliance to provide low-cost vaccines to help prevent of rotavirus-related diarrhoea in children in the developing world.
GSK Going Global – CNBC US interview - May 2011
GSK CEO Andrew Witty describes GSK's business strategy and approach to improving global health to CNBC US in May 2011.
Health Affairs - January 2011
GSK CEO Andrew Witty shares his views on innovation in global health in the January 2011 edition of Health Affairs
The Innovation Challenge - November 2010
GSK CEO Andrew Witty featured in The Economist publication The World in 2011 published in November 2010
The Times Eureka 100 Science List - October 2010
GSK CEO Andrew Witty featured at number 14 in the The Times 100 Science List published in October 2010.
